These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36660014)

  • 21. SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation.
    Lindsay J; Othman J; Kong Y; Yip A; Van Hal S; Larsen S; Bryant C; Gibson J; Kerridge I; Fay K; Stevenson W; Arthur C; Chen SCA; Kong DCM; Greenwood M; Pergam SA; Liu C; Slavin MA
    Open Forum Infect Dis; 2021 Nov; 8(11):ofab502. PubMed ID: 35559121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
    Singh S; Chandra U; Anchan VN; Verma P; Tilak R
    Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole.
    Kanda Y; Kami M; Matsuyama T; Mitani K; Chiba S; Yazaki Y; Hirai H
    Hematol Oncol; 1998 Mar; 16(1):33-7. PubMed ID: 9821410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between plasma hydroxylated metabolite of itraconazole and serum creatinine in patients with a hematopoietic or immune-related disorder.
    Imoto Y; Naito T; Miyadera Y; Ono T; Kawakami J
    Eur J Clin Pharmacol; 2021 Mar; 77(3):369-379. PubMed ID: 33033881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
    Khattab F; Elkholy BM; Taha M; Abd-Elbaset A; Fawzy M
    Mycoses; 2022 Dec; 65(12):1194-1201. PubMed ID: 35943822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
    Oakley KL; Morrissey G; Denning DW
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).
    Tell LA; Craigmill AL; Clemons KV; Sun Y; Laizure SC; Clifford A; Ina JH; Nugent-Deal JP; Woods L; Stevens DA
    J Vet Pharmacol Ther; 2005 Jun; 28(3):267-74. PubMed ID: 15953200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of itraconazole and its CYP3A4-mediated metabolites including
    Imoto Y; Mino Y; Naito T; Ono T; Kawakami J
    J Pharm Health Care Sci; 2020; 6():11. PubMed ID: 32391164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients.
    Prentice AG; Warnock DW; Johnson SA; Phillips MJ; Oliver DA
    J Antimicrob Chemother; 1994 Aug; 34(2):247-52. PubMed ID: 7814285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
    Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
    Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole.
    DiNunzio JC; Miller DA; Yang W; McGinity JW; Williams RO
    Mol Pharm; 2008; 5(6):968-80. PubMed ID: 19434851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles.
    Chen W; Gu B; Wang H; Pan J; Lu W; Hou H
    Int J Pharm; 2008 Oct; 362(1-2):133-40. PubMed ID: 18585448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semi-micro column HPLC of triazolam in rat plasma and brain microdialysate and its application to drug interaction study with itraconazole.
    Nakashima K; Yamamoto K; Al-Dirbashi OY; Kaddoumi A; Nakashima MN
    J Pharm Biomed Anal; 2003 Jan; 30(6):1809-16. PubMed ID: 12485722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of itraconazole, hydroxy itraconazole, keto itraconazole and N-desalkyl itraconazole concentration in human plasma using liquid chromatography with tandem mass spectrometry.
    Liang X; Van Parys M; Ding X; Zeng N; Bi L; Dorshort D; McKnight J; Milanowski D; Mao J; Chen Y; Ware JA; Dean B; Hop CE; Deng Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1020():111-9. PubMed ID: 27038403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats.
    Yang W; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2010 May; 75(1):33-41. PubMed ID: 20102737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
    Bian X; Liang S; John J; Hsiao CH; Wei X; Liang D; Xie H
    Int J Nanomedicine; 2013; 8():4521-31. PubMed ID: 24311942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of Hydroxy-Itraconazole in Relation to Itraconazole Bloodstream Concentrations.
    Wiederhold NP; Schwartz IS; Patterson TF; Thompson GR
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections].
    Uchida K; Yamaguchi H; Shibuya K
    Jpn J Antibiot; 1991 May; 44(5):588-99. PubMed ID: 1652657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of itraconazole metabolites in CYP3A4 inhibition.
    Isoherranen N; Kunze KL; Allen KE; Nelson WL; Thummel KE
    Drug Metab Dispos; 2004 Oct; 32(10):1121-31. PubMed ID: 15242978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Nanomedicine; 2012; 7():5475-89. PubMed ID: 23093903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.